Recursion Pharmaceuticals has set terms for a major $306 million IPO as the artificial intelligence biotech eyes a $3 billion valuation. That’s a lot of money, though Recursion is used to that: The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback